AGE Pill Ingredients: Scientists unveil a giant leap forward in anti-aging – boosting NAD+, short for Nicotinamide Adenine Dinucleotide

UNSW researchers have made a discovery that could lead to a revolutionary formula that actually reverses ageing, improves DNA repair and could even help NASA get its astronauts to Mars.

In a paper published in Science Today, the team identifies a critical step in the molecular process that allows cells to repair damaged DNA.

Their experiments in mice suggest a treatment is possible for DNA damage from ageing and radiation. It is so promising it has attracted the attention of NASA, which believes this new discovery can help its mission to Mars program.

While our cells have an innate capability to repair DNA damage—which happens every time we go out into the sun, for example – their ability to do this declines as we age.

The scientists identified that the metabolite NAD+, which is naturally present in every cell of our body, has a key role as a regulator in protein-to-protein interactions that control DNA repair.

Treating mice with a NAD+ precursor, or “booster,” was shown to improved their cells’ ability to repair DNA damage caused by radiation exposure or old age.

“The cells of the old mice were indistinguishable from the young mice, after just one week of treatment,” said lead author Professor David Sinclair of UNSW School of Medical Sciences and Harvard Medical School Boston.

Human trials of NAD+ boosting therapy began in the Fall of 2017.

“This is the closest we are to a safe and effective anti-ageing drug that’s perhaps only three to five years away from being on the market if the trials go well,” says Sinclair, who maintains a lab at UNSW in Sydney.

Dr. Sinclair NAD+ discovery
Dr. David Sinclair, Harvard Medical School

The work has excited NASA, which is currently focused on the challenge of keeping its astronauts healthy during a four-year mission to Mars.

Even during short missions, astronauts experience accelerated ageing from cosmic radiation, suffering muscle weakness, memory loss and other symptoms when they return. On the journey to Mars, the situation would be far worse: five per cent of the astronauts’ cells would die and their chances of cancer would approach 100 per cent.

Professor Sinclair and his UNSW colleague Dr. Lindsay Wu were winners in NASA’s iTech competition in December last year because of their discovery of NAD+’s role in DNA repair.

“We came in with a solution for a biological problem and it won the competition out of 300 entries,” Dr. Wu says.

Professor David Sinclair and his UNSW team.

Cosmic radiation is not only an issue for astronauts. We’re all exposed to it aboard commercial aircraft, with a London-Singapore-Melbourne flight roughly equivalent in radiation to a chest x-ray. Recent studdies have show that flight attendants have a 50% higher incidence of many types of cancer from their increased exposure to cosmic radiation during their flying career.

In theory, the same treatment could mitigate the effects of DNA damage for flight attendants and frequent flyers. The other group that could benefit from this work is survivors of childhood cancers, who have been exposed to radiation treatment.

Dr. Wu says 96 per cent of childhood cancer survivors suffer a chronic illness by age 45, including cardiovascular disease, Type 2 diabetes, Alzheimer’s disease, and cancers unrelated to the original cancer.

“All of this adds up to the fact they have accelerated ageing, which is devastating,” he says.
“It would be great to do something about that, and we believe we can with this molecule, NAD+”

For the past four years, Professor Sinclair and Dr. Wu have been working on making an NAD+ boosting pharmaceutical drug with their companies MetroBiotech NSW and MetroBiotech International.

The pharmaceutical version of an NAD+ booster is at least 3-5 years away and will likely be significantly more expensive after Human Trials, FDA approvals, and the legal patent process. Many of the scientists involved in the Harvard and UNSW research are already taking NAD+ boosting “nutritional supplements” just like Sisel’s A.G.E. Pill – to start experiencing incredible results Now! What are you waiting for?

Human trials have begun this year at Brigham and Women’s Hospital, in Boston.

Sisel is the first to bring a comprehensive NAD+ boosting nutraceutical product to market containing these exciting new anti-aging discoveries: NAD+ precursor NR and proprietary supporting ingredients – which the body readily converts into NAD+, thereby safely increasing NAD+ levels at a cellular level.

To ORDER Your AGE Pills:

New Human Clinical Trials

Click on the Image Above to view Third Human Clinical Trial on Boosting NAD+ levels with NR…

Click on the image above to read the latest study on AGE Pill Ingredient NR’s safety and effectiveness in Human test subjects

Click on the Image Above to view First Human Clinical Trial on Boosting NAD+ levels with NR…

Click on the Image Above to learn about Autoimmune Disease Reversal with AGE Pill ingredient NR…

age pill alzheimers

Click on the Image Above to view new scientific study on Alzheimers Disease improvements from treatment with NR…

If you haven’t tried The A.G.E. Pill yet, click on the button below to Order Yours on-line…

For assistance placing your Order, call: (949) 391-1889

Jackie Christiansen Sisel AGE Pill

To ORDER Your AGE Pills: